Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shane R Stecklein

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
JCO Global Oncology|October 27, 2020
Radiation Sciences Education in Africa: An Assessment of Current Training Practices and Evaluation of a High-Yield Course in Radiation Biology and Radiation PhysicsShane R Stecklein, Cullen M Taniguchi, Adam D Melancon, et al.
Molecular Oncology|August 3, 2021
Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasionEmilly S Villodre, Xiaoding Hu, Richard Larson, et al.
International Journal of Radiation Oncology, Biology, Physics|September 27, 2025
Analysis of the Radiosensitivity Index in Paired Preneoadjuvant and Postneoadjuvant Therapy Triple-Negative Breast CancerShane R Stecklein, Roberto Salgado, Julia R White, et al.
JAMA Oncology|November 22, 2023
Clinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer: NeoPACT Phase 2 Clinical TrialPriyanka Sharma, Shane R Stecklein, Rachel Yoder, et al.
NPJ Breast Cancer|July 11, 2022
Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancerRachel Yoder, Bruce F Kimler, Joshua M Staley, et al.
Breast Cancer Research and Treatment|May 9, 2014
Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testingPriyanka Sharma, Jennifer R Klemp, Bruce F Kimler, et al.
International Journal of Radiation Oncology, Biology, Physics|September 28, 2021
Breast Radiation Therapy-Related Treatment Outcomes in Patients With or Without Germline Mutations on Multigene Panel TestingBhavana V Chapman, Diane Liu, Yu Shen, et al.
Practical Radiation Oncology|August 21, 2018
Prospective Comparison of Toxicity and Cosmetic Outcome After Accelerated Partial Breast Irradiation With Conformal External Beam Radiotherapy or Single-Entry Multilumen Intracavitary BrachytherapyShane R Stecklein, Simona F Shaitelman, Gildy V Babiera, et al.
International Journal of Radiation Oncology, Biology, Physics|October 5, 2021
Outcomes After Breast Radiation Therapy in a Diverse Patient Cohort With a Germline BRCA1/2 MutationBhavana V Chapman, Diane Liu, Yu Shen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2024
Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant ChemotherapyMiguel Martín, Rachel Yoder, Roberto Salgado, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
JCO Global Oncology|October 27, 2020
Radiation Sciences Education in Africa: An Assessment of Current Training Practices and Evaluation of a High-Yield Course in Radiation Biology and Radiation PhysicsShane R Stecklein, Cullen M Taniguchi, Adam D Melancon, et al.
Molecular Oncology|August 3, 2021
Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasionEmilly S Villodre, Xiaoding Hu, Richard Larson, et al.
International Journal of Radiation Oncology, Biology, Physics|September 27, 2025
Analysis of the Radiosensitivity Index in Paired Preneoadjuvant and Postneoadjuvant Therapy Triple-Negative Breast CancerShane R Stecklein, Roberto Salgado, Julia R White, et al.
JAMA Oncology|November 22, 2023
Clinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer: NeoPACT Phase 2 Clinical TrialPriyanka Sharma, Shane R Stecklein, Rachel Yoder, et al.
NPJ Breast Cancer|July 11, 2022
Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancerRachel Yoder, Bruce F Kimler, Joshua M Staley, et al.
Breast Cancer Research and Treatment|May 9, 2014
Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testingPriyanka Sharma, Jennifer R Klemp, Bruce F Kimler, et al.
International Journal of Radiation Oncology, Biology, Physics|September 28, 2021
Breast Radiation Therapy-Related Treatment Outcomes in Patients With or Without Germline Mutations on Multigene Panel TestingBhavana V Chapman, Diane Liu, Yu Shen, et al.
Practical Radiation Oncology|August 21, 2018
Prospective Comparison of Toxicity and Cosmetic Outcome After Accelerated Partial Breast Irradiation With Conformal External Beam Radiotherapy or Single-Entry Multilumen Intracavitary BrachytherapyShane R Stecklein, Simona F Shaitelman, Gildy V Babiera, et al.
International Journal of Radiation Oncology, Biology, Physics|October 5, 2021
Outcomes After Breast Radiation Therapy in a Diverse Patient Cohort With a Germline BRCA1/2 MutationBhavana V Chapman, Diane Liu, Yu Shen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2024
Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant ChemotherapyMiguel Martín, Rachel Yoder, Roberto Salgado, et al.
Pageof 4